Level Biotechnology Inc. (TPEX:3118)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.75
+0.20 (0.60%)
Apr 29, 2026, 1:21 PM CST
5.97%
Market Cap 1.10B
Revenue (ttm) 736.59M
Net Income (ttm) 79.70M
Shares Out 32.45M
EPS (ttm) 2.44
PE Ratio 13.83
Forward PE n/a
Dividend 2.20 (6.56%)
Ex-Dividend Date Jun 12, 2025
Volume 33,442
Average Volume 27,349
Open 33.90
Previous Close 33.55
Day's Range 33.60 - 33.90
52-Week Range 31.10 - 34.60
Beta 0.27
RSI 59.00
Earnings Date May 6, 2026

About Level Biotechnology

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei Ci... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 128
Stock Exchange Taipei Exchange
Ticker Symbol 3118
Full Company Profile

Financial Performance

In 2025, Level Biotechnology's revenue was 736.59 million, an increase of 0.72% compared to the previous year's 731.35 million. Earnings were 79.70 million, an increase of 22.97%.

Financial Statements

News

There is no news available yet.